Prevention of Type 2 Diabetic Nephropathy


M.R Ganji 1 , F Darvishzadeh 1 , I Najafi 1 , M.S Hakemi 1 , B Larijani 2 , * , 1


2 Department of Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, [email protected], Iran

How to Cite: Ganji M, Darvishzadeh F, Najafi I, Hakemi M, Larijani B, et al. Prevention of Type 2 Diabetic Nephropathy , Iran Red Crescent Med J. Online ahead of Print ; 8(2):83-91.


Iranian Red Crescent Medical Journal: 8 (2); 83-91
Article Type: Review Article


Diabetes Mellitus is a Major health problem in the most of word countries. In Northern America the population with type II diabetes will exceeds 300 millions in the next 25 years. In Iran, overall prevalence of diabetes mellitus is between 3.7% and 6% in rural and urban regions respectively. Prevalence of nephropathy among diabetic patients is 10% and 22.4% of all dialysis cases is related to diabetes. Protenuria necreases the cardiovascular death by 10 folds in subjects with type 1 diabetes. Similary in type 2 diabetes, microalbuminuria is a risk tactor for CHD by its association with both endothelial damage and nephropathy. Studies have suggested that prevention of the progression of diabetic nephropathy is associated with lower risk of cardiovascular death. Control of the modifiable risk factors such as blood glucose level, hyperlipidemia, hypertension, diet, smoking and proteinuria is necessary to prevent the disabilities and severe consequences of diabetes. This discussion is based on all available prospective studies to intervene contributing factors for prevention. It was tried to include EVIDENCE BASED MEDICINE grade A1 and A2 as explained separately. 

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF